Actemra 200mg, a treatment known scientifically as tocilizumab, represents a potent pharmaceutical agent primarily employed for the treatment of rheumatoid arthritis. This remarkable agent acts by inhibiting the activity of interleukin-6 (IL-6), a regulatory protein essential in the inflammatory process. Moreover, Actemra exhibits effectiveness in